These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8218935)

  • 1. Murine interferon-gamma enhances resistance to infection with strains of Pseudomonas aeruginosa in mice.
    Pierangeli SS; Polk HC; Parmely MJ; Sonnenfeld G
    Cytokine; 1993 May; 5(3):230-4. PubMed ID: 8218935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
    Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE
    Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of murine macrophages with murine interferon-gamma and tumour necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa.
    Pierangeli SS; Sonnenfeld G
    Clin Exp Immunol; 1993 Aug; 93(2):165-71. PubMed ID: 8348741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant murine gamma interferon induces enhanced resistance to Listeria monocytogenes infection in neonatal mice.
    Chen Y; Nakane A; Minagawa T
    Infect Immun; 1989 Aug; 57(8):2345-9. PubMed ID: 2501217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
    Reiners JJ; Pavone A; Rupp T; Cantu AR
    Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury.
    Bohannon J; Fang G; Cui W; Sherwood E; Toliver-Kinsky T
    Shock; 2009 Oct; 32(4):435-41. PubMed ID: 19752689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
    Pinto M; Zehavi-Willner T
    Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice.
    Stevens MG; Pugh GW; Tabatabai LB
    Infect Immun; 1992 Oct; 60(10):4407-9. PubMed ID: 1398950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans.
    Garner RE; Kuruganti U; al-Hussaini LA; Czarniecki CW; Domer JE
    Infect Immun; 1992 May; 60(5):1927-35. PubMed ID: 1563784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression.
    Murphey ED; Sherwood ER
    Shock; 2006 Oct; 26(4):417-24. PubMed ID: 16980891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-γ-treated macrophages to Pseudomonas aeruginosa infection.
    Singh S; Barr H; Liu YC; Robins A; Heeb S; Williams P; Fogarty A; Cámara M; Martínez-Pomares L
    PLoS One; 2015; 10(2):e0117447. PubMed ID: 25706389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
    Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S
    Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interferon-gamma treatment on the course of a burn wound infection.
    Hershman MJ; Sonnenfeld G; Logan WA; Pietsch JD; Wellhausen SR; Polk HC
    J Interferon Res; 1988 Jun; 8(3):367-73. PubMed ID: 3137276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of
    Lenzmeier TD; Mudaliar NS; Stanbro JA; Watters C; Ahmad A; Simons MP; Ventolini G; Zak JC; Colmer-Hamood JA; Hamood AN
    J Med Microbiol; 2019 Oct; 68(10):1560-1572. PubMed ID: 31460863
    [No Abstract]   [Full Text] [Related]  

  • 19. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential efficacies of recombinant murine interferon-gamma and recombinant human interleukin 2 against EL4-bearing mice.
    Maekawa R; Kitagawa T; Hojo K; Sato K
    J Interferon Res; 1988 Apr; 8(2):241-9. PubMed ID: 3132514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.